All Stories

  1. Molecular Dynamics-Ensemble Docking and Biophysical Studies for Structure-Based Identification of Non-Amino Acidic Ligands of DDAH-1
  2. Chromatographic enantioresolution and stereochemical characterization of synthetic cannabinoid receptor agonists with Whelk-O®1 chiral stationary phases under mass spectrometry compatible reversed-phase conditions: A study case with seized samples
  3. A journey in unraveling the enantiorecognition mechanism of 3,5-dinitrobenzoyl-amino acids with two Cinchona alkaloid-based chiral stationary phases: The power of molecular dynamic simulations
  4. Discovery and Structure–Activity Relationships of Novel ssDAF-12 Receptor Modulators
  5. Turning a Tumor Microenvironment Pitfall into Opportunity: Discovery of Benzamidoxime as PD-L1 Ligand with pH-Dependent Potency
  6. Multiple Heart-Cutting Two-Dimensional HPLC-UV Achiral–Chiral Analysis of Branched-Chain Amino Acids in Food Supplements under Environmentally Friendly Conditions
  7. Synthesis and Characterization of Chiral Iridium Complexes Bearing Carbohydrate Functionalized Pyridincarboxamide Ligands and Their Application as Catalysts in the Asymmetric Transfer Hydrogenation of α-Ketoacids in Water
  8. Environmentally Sustainable Achiral and Chiral Chromatographic Analysis of Amino Acids in Food Supplements
  9. Novel analgesic/anti-inflammatory agents: 1,5-Diarylpyrrole nitrooxyethyl sulfides and related compounds as Cyclooxygenase-2 inhibitors containing a nitric oxide donor moiety endowed with vasorelaxant properties
  10. Combining molecular modeling approaches to establish the chromatographic enantiomer elution order in the absence of pure enantiomeric standards: A study case with two tetracyclic quinolines
  11. Elucidation of retention mechanism of dipeptides on a Ristocetin A-based chiral stationary phase using a combination of chromatographic and molecular simulation techniques
  12. Critical Assessment of a Structure-Based Screening Campaign for IDO1 Inhibitors: Tips and Pitfalls
  13. Enantioseparation of novel anti-inflammatory chiral sulfoxides with two cellulose dichlorophenylcarbamate-based chiral stationary phases and polar-organic mobile phase(s)
  14. Efficient enantioresolution of aromatic α-hydroxy acids with Cinchona alkaloid-based zwitterionic stationary phases and volatile polar-ionic eluents
  15. Original enantioseparation of illicit fentanyls with cellulose-based chiral stationary phases under polar-ionic conditions
  16. Recent advances in urea- and thiourea-containing compounds: focus on innovative approaches in medicinal chemistry and organic synthesis
  17. Synthesis and biological activity of cyclopropyl Δ7-dafachronic acids as DAF-12 receptor ligands
  18. Profiling calcium-dependent interactions between Sorcin and intrinsically disordered regions of human proteome
  19. Integrating experimental and computational techniques to study chromatographic enantioresolutions of chiral tetrahydroindazole derivatives
  20. Fragment-based Design of Zwitterionic, Strong Cation- and Weak Anion-Exchange Type Mixed-mode Liquid Chromatography Ligands and their Chromatographic Exploration
  21. New Insights from Crystallographic Data: Diversity of Structural Motifs and Molecular Recognition Properties between Groups of IDO1 Structures.
  22. Chromatograpic resolution of phenylethanolic-azole racemic compounds highlighted stereoselective inhibition of heme oxygenase-1 by (R)-enantiomers
  23. Binding modes identification through molecular dynamic simulations: a case study with carnosine enantiomers and the Teicoplanin A2‐2‐based chiral stationary phase
  24. Discovery of Novel 5-Lipoxygenase-Activating Protein (FLAP) Inhibitors by Exploiting a Multistep Virtual Screening Protocol
  25. Enantioselective HPLC Analysis to Assist the Chemical Exploration of Chiral Imidazolines
  26. Computational studies in enantioselective liquid chromatography: Forty years of evolution in docking- and molecular dynamics-based simulations
  27. Tracking Hidden Binding Pockets Along the Molecular Recognition Path of l ‐Trp to Indoleamine 2,3‐Dioxygenase 1
  28. Mixed-mode Chromatography Characteristics of Chiralpak ZWIX(+) and ZWIX(–) and Elucidation of their Chromatographic Orthogonality for LC×LC Application
  29. Exploiting Chemical Toolboxes for the Expedited Generation of Tetracyclic Quinolines as a Novel Class of PXR Agonists
  30. Dissecting the allosteric FXR modulation: a chemical biology approach using guggulsterone as a chemical tool
  31. Hydrophilic interaction liquid chromatography of aminoglycoside antibiotics with a diol-type stationary phase
  32. α-Amino-β-carboxymuconate-ε-semialdehyde Decarboxylase (ACMSD) Inhibitors as Novel Modulators of De Novo Nicotinamide Adenine Dinucleotide (NAD+) Biosynthesis
  33. Elucidation of the Chromatographic Enantiomer Elution Order Through Computational Studies
  34. Synthesis, physicochemical properties, and biological activity of bile acids 3-glucuronides: Novel insights into bile acid signalling and detoxification
  35. Exploring the enantiorecognition mechanism of Cinchona alkaloid-based zwitterionic chiral stationary phases and the basic trans -paroxetine enantiomers
  36. Targeting Wnt-driven cancers: Discovery of novel tankyrase inhibitors
  37. Binding properties of different categories of IDO1 inhibitors: a microscale thermophoresis study
  38. Reshaping antibiotics through hydrophobic drug-bile acid ionic complexation enhances activity against Staphylococcus aureus biofilms
  39. Enantioresolution and stereochemical characterization of two chiral sulfoxides endowed with COX-2 inhibitory activity
  40. A rational approach to elucidate human monoamine oxidase molecular selectivity
  41. N-Decyl-S-trityl-(R)-cysteine, a new chiral selector for “green” ligand-exchange chromatography applications
  42. Discovery of 3α,7α,11β-Trihydroxy-6α-ethyl-5β-cholan-24-oic Acid (TC-100), a Novel Bile Acid as Potent and Highly Selective FXR Agonist for Enterohepatic Disorders
  43. Synthesis and biological evaluation of C(5)-substituted derivatives of leukotriene biosynthesis inhibitor BRP-7
  44. The “racemic approach” in the evaluation of the enantiomeric NorA efflux pump inhibition activity of 2-phenylquinoline derivatives
  45. Docking Studies and Molecular Dynamic Simulations Reveal Different Features of IDO1 Structure
  46. 4,5-Diarylisoxazol-3-carboxylic acids: A new class of leukotriene biosynthesis inhibitors potentially targeting 5-lipoxygenase-activating protein (FLAP)
  47. Mechanistic considerations of enantiorecognition on novel Cinchona alkaloid-based zwitterionic chiral stationary phases from the aspect of the separation of trans-paroxetine enantiomers as model compounds
  48. The Janus-faced nature of IDO1 in infectious diseases: challenges and therapeutic opportunities
  49. Quinine-Based Zwitterionic Chiral Stationary Phase as a Complementary Tool for Peptide Analysis: Mobile Phase Effects on Enantio- and Stereoselectivity of Underivatized Oligopeptides
  50. Concepts and Molecular Aspects in the Polypharmacology of PARP-1 Inhibitors
  51. Diastereo- and enantioseparation of a Nα-Boc amino acid with a zwitterionic quinine-based stationary phase: Focus on the stereorecognition mechanism
  52. N-Aryl-5-aminopyrazole: A Versatile Architecture in Medicinal Chemistry
  53. Beyond Bile Acids: Targeting Farnesoid X Receptor (FXR) with Natural and Synthetic Ligands
  54. Scaffold hopping approach on the route to selective tankyrase inhibitors
  55. Investigating the allosteric reverse signalling of PARP inhibitors with microsecond molecular dynamic simulations and fluorescence anisotropy
  56. Enantioresolution, stereochemical characterization and biological activity of a chiral large-conductance calcium-activated potassium channel opener
  57. Ketoprofen enantioseparation with a Cinchona alkaloid based stationary phase: Enantiorecognition mechanism and release studies
  58. Flow synthesis and biological activity of aryl sulfonamides as selective carbonic anhydrase IX and XII inhibitors
  59. Chromatographic separation of free dafachronic acid epimers with a novel triazole click quinidine-based chiral stationary phase
  60. Design, Synthesis, Crystallographic Studies, and Preliminary Biological Appraisal of New Substituted Triazolo[4,3- b ]pyridazin-8-amine Derivatives as Tankyrase Inhibitors
  61. One-pot, telescoped synthesis of N-aryl-5-aminopyrazoles from anilines in environmentally benign conditions
  62. From Polypharmacology to Target Specificity: The Case of PARP Inhibitors
  63. Synthesis and Biological Evaluation of Direct Thrombin Inhibitors Bearing 4-(Piperidin-1-yl)pyridine at the P1 Position with Potent Anticoagulant Activity
  64. Exploring the effect of PARP-1 flexibility in docking studies
  65. Asymmetric synthesis of the four diastereoisomers of a novel non-steroidal farnesoid X receptor (FXR) agonist: Role of the chirality on the biological activity
  66. Navigations of chemical space to further the understanding of polypharmacology in human nuclear receptors
  67. Chiral mobile phase in ligand-exchange chromatography of amino acids: Exploring the copper(II) salt anion effect with a computational approach
  68. Pyrazole[3,4-e][1,4]thiazepin-7-one derivatives as a novel class of Farnesoid X Receptor (FXR) agonists
  69. Extending SAR of bile acids as FXR ligands: Discovery of 23-N-(carbocinnamyloxy)-3α,7α-dihydroxy-6α-ethyl-24-nor-5β-cholan-23-amine
  70. Expanding the horizon of chemotherapeutic targets: From MDM2 to MDMX (MDM4)
  71. Discovery and characterization of novel potent PARP-1 inhibitors endowed with neuroprotective properties: From TIQ-A to HYDAMTIQ
  72. Molecular Interaction Fields and 3D-QSAR Studies of p53−MDM2 Inhibitors Suggest Additional Features of Ligand−Target Interaction
  73. Quantum mechanics/molecular mechanics (QM/MM) modeling of the irreversible transamination of l-kynurenine to kynurenic acid: The round dance of kynurenine aminotransferase II
  74. Targeting the conformational transitions of MDM2 and MDMX: Insights into key residues affecting p53 recognition
  75. Fluorinated Benzyloxyphenyl Piperidine-4-carboxamides with Dual Function against Thrombosis: Inhibitors of Factor Xa and Platelet Aggregation
  76. Targeting the Conformational Transitions of MDM2 and MDMX: Insights into Dissimilarities and Similarities of p53 Recognition
  77. Sequence Variants in Kynurenine Aminotransferase II (KAT II) Orthologs Determine Different Potencies of the InhibitorS-ESBA
  78. An Integrated Approach to Ligand- and Structure-Based Drug Design: Development and Application to a Series of Serine Protease Inhibitors
  79. Synthesis and Monoamine Oxidase Inhibitory Activity of New Pyridazine-, Pyrimidine- and 1,2,4-Triazine-Containing Tricyclic Derivatives
  80. Ester derivatives of annulated tetrahydroazocines: A new class of selective acetylcholinesterase inhibitors
  81. Structural Insights into Monoamine Oxidase Inhibitory Potency and Selectivity of 7-Substituted Coumarins from Ligand- and Target-Based Approaches
  82. The natural mutation by deletion of Lys9 in the thrombin A-chain affects the pKa value of catalytic residues, the overall enzyme's stability and conformational transitions linked to Na+ binding
  83. Lipophilicity-related inhibition of blood platelet aggregation by nipecotic acid anilides
  84. A Natural Prothrombin Mutant Reveals an Unexpected Influence of A-chain Structure on the Activity of Human  -Thrombin
  85. High affinity central benzodiazepine receptor ligands. Part 3: insights into the pharmacophore and pattern recognition study of intrinsic activities of pyrazolo[4,3- c ]quinolin-3-ones
  86. Investigation on the antiplatelet activity of pyrrolo[3,2-c]pyridine-containing compounds
  87. Natural and synthetic geiparvarins are strong and selective MAO-B inhibitors. synthesis and SAR studies